Prelude Therapeutics Inc
Prelude Therapeutics Inc (PRLD) Historical Volatility
PRLD 30-day historical volatility is 82%. This ranks in the 8th percentile of readings over the past year.
Read more
Tracking PRLD historical volatility helps you see how much Prelude Therapeutics Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Prelude Therapeutics Inc's HV tells you what really happened. Use our scanner to monitor PRLD 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The PRLD 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Prelude Therapeutics Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors.
The company was incorporated in 2016 and is headquartered in Wilmington, Delaware.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Prelude Therapeutics Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where PRLD HV is running hot, cold, or in line. Make the PRLD 30 day historical volatility — and every other window — work for your edge instead of against it.
As of September 17, 2026
As of September 17, 2026
See how volatility has moved over time
Track PRLD historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→